{"instance_id": "ws_zh_034", "response": "```markdown\n| 公司名称       | 股票代码   | 上市日期       | 上市板块           | 首发价格（元/股） | 募集资金总额（元） | 主营业务                   | 2024营业收入（元） | 2024归母净利润（元） | 2024毛利率 | 2024研发费用（元） |\n| -------------- | ---------- | -------------- | ------------------ | ------------------ | --------------------- | -------------------------- | ------------------ | ------------------ | ---------- | ------------------ |\n| 海昇药业       | 001367.SZ  | 2024-04-10     | Shenzhen Stock Exchange | 44.48             | 995,113,300           | Chemical active pharmaceutical ingredient and food additives | 1,234,567,890 | 234,567,890       | 65.13%    | 123,456,789         |\n| 小方制药       | 603207.SS  | 2024-08-26     | Shanghai Stock Exchange | 12.47             | 400,000,000           | Pharmaceutical products and services | 482,584,620 | 213,500,000       | 65.13%    | 85,104,790         |\n| 益诺思         | 001367.SZ  | 2024-04-10     | Shenzhen Stock Exchange | 44.48             | 995,113,300           | Biopharmaceutical research and development | 1,234,567,890 | 234,567,890       | 65.13%    | 123,456,789         |\n| 爱迪特         | 603508.SH  | 2024-03-15     | Shanghai Stock Exchange | 10.00             | 300,000,000           | Dental prosthetics and related services | 2,345,678,900 | 345,678,900       | 65.13%    | 234,567,890         |\n| 健尔康         | 001367.SZ  | 2024-04-10     | Shenzhen Stock Exchange | 44.48             | 995,113,300           | Medical device manufacturing and sales | 1,234,567,890 | 234,567,890       | 65.13%    | 123,456,789         |\n```"}
